|
Market Closed -
Bombay S.E.
06:02:27 2026-09-07 EDT
|
5-day change | 1st Jan Change | ||
| 751.00 INR | 0.00% |
|
-2.21% | -7.42% |
| 08-21 | Mercury Laboratories Limited Announces Executive Changes, Effective August 21, 2026 | CI |
| 07-25 | Mercury Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 840M 8.9M 7.66M 7.2M 6.58M 12.31M 12.34M 85.12M 33.03M 431M 33.41M 32.68M 1.39B | P/E 2024 |
17.7x | P/E 2025 | 31.3x |
|---|---|---|---|---|---|
| Enterprise Value | 879M 9.31M 8.01M 7.54M 6.88M 12.88M 12.91M 89.06M 34.56M 451M 34.96M 34.19M 1.45B | EV / Sales 2024 |
1.29x | EV / Sales 2025 | 1.36x |
| Free-Float |
13.68% | Yield 2024 |
0.42% | Yield 2025 | 0.43% |
| 1 week | -2.21% | ||
| Current month | -2.21% | ||
| 1 month | -4.37% | ||
| 3 months | -3.41% | ||
| 6 months | -3.10% | ||
| Current year | -7.42% |
| 1 week | 751 |  | 770 |
| 1 month | 745 | | 800 |
| Current year | 620.55 | | 928.5 |
| 1 year | 620.55 | | 942.9 |
| 3 years | 620.55 | | 1,303 |
| 5 years | 390 | | 1,303 |
| 10 years | 212 | | 1,303 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 74 | 1982-02-15 | |
Ashish Vasavada
DFI | Director of Finance/CFO | 54 | 2021-10-20 |
Saurabh Mittal
COO | Chief Operating Officer | 41 | 2023-11-07 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 2015-02-22 | |
| Director/Board Member | 71 | 1982-02-15 | |
Paresh Mistry
BRD | Director/Board Member | 57 | 2017-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -2.21% | -10.60% | -7.07% | 9.55M | |
| -1.32% | +1.33% | +77.46% | +41.17% | 371B | |
| -0.81% | -3.02% | +21.50% | -19.50% | 68.64B | |
| -0.51% | +4.59% | +47.06% | +168.63% | 12.51B | |
| -0.56% | -9.06% | -8.11% | -8.78% | 8.06B | |
| +0.23% | -1.59% | -20.70% | +6.13% | 5.04B | |
| 0.00% | -4.12% | -31.60% | +20.55% | 4.51B | |
| -0.35% | -3.11% | -33.77% | +1.20% | 3.07B | |
| -1.00% | -0.46% | -5.37% | +37.45% | 2.53B | |
| -0.50% | -3.98% | -24.35% | -16.61% | 2B | |
| Average | -0.49% | -1.96% | +1.15% | +22.32% | 47.73B | |
| Weighted average by Cap. | -1.18% | +0.47% | +63.52% | +33.85% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 756M 8M 6.89M 6.48M 5.92M 11.07M 11.1M 76.56M 29.71M 388M 30.05M 29.4M 1.25B | 751M 7.95M 6.84M 6.44M 5.88M 11.01M 11.04M 76.1M 29.53M 385M 29.87M 29.22M 1.24B |
| Net income | 56.54M 599K 515K 485K 443K 829K 831K 5.73M 2.22M 29.01M 2.25M 2.2M 93.46M | 31.45M 333K 287K 270K 246K 461K 462K 3.19M 1.24M 16.14M 1.25M 1.22M 51.98M |
| Net Debt | -25.4M -269K -232K -218K -199K -372K -373K -2.57M -999K -13.03M -1.01M -988K -41.99M | 38.95M 412K 355K 334K 305K 571K 572K 3.95M 1.53M 19.98M 1.55M 1.52M 64.37M |
Employees
503
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-07 | ₹751.00 | 0.00% | 3 |
| 26-09-03 | ₹751.00 | -0.29% | 10 |
| 26-09-02 | ₹753.20 | +0.01% | 34 |
| 26-09-01 | ₹753.10 | -1.94% | 8 |
| 26-08-31 | ₹768.00 | -0.73% | 5 |
- Stock Market
- Stocks
- MERCURYLAB6 Stock
Select your edition
All financial news and data tailored to specific country editions
